Behavioral and clinical correlates of serum bilirubin concentrations in Japanese men and women
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vítek L, Schwertner HA: The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem. 2007, 43: 1-57.
Schwertner HA, Vítek L: Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008, 198: 1-11. 10.1016/j.atherosclerosis.2008.01.001.
Abraham NG, Kappas A: Pharmacological and clinical aspects of hemo oxygenase. Pharmacol Rev. 2008, 60: 79-127. 10.1124/pr.107.07104.
Ohnaka K, Kono S: Bilirubin, cardiovascular diseases and cancer: epidemiological perspectives. Expert Rev Endocrinol Metab. 2010, 5: 891-904. 10.1586/eem.10.65.
Takayanagi R, Inoguchi T, Ohnaka K: Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. J Clin Biochem Nutr. 2011, 48: 72-77.
Zucker SD, Horn PS, Sherman KE: Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004, 40: 827-835.
Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I: Serum bilirubin and risk of respiratory disease and death. JAMA. 2011, 305: 691-697. 10.1001/jama.2011.124.
Van Hoydonck PG, Temme EH, Schouten EG: Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int J Epidemiol. 2001, 30: 1465-1472. 10.1093/ije/30.6.1465.
Schwertner HA: Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis. 1998, 136: 383-387. 10.1016/S0021-9150(97)00232-3.
Temme EH, Zhang J, Schouten EG, Kesteloot H: Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 2001, 12: 887-894. 10.1023/A:1013794407325.
Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, Ducimetière P, Patterson CC, Kee F, Yarnell JW, Evans A: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil. 2007, 14: 79-84. 10.1097/01.hjr.0000230097.81202.9f.
Kimm H, Yun JE, Jo J, Jee SH: Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke. 2009, 40: 3422-3427. 10.1161/STROKEAHA.109.560649.
Bhuiyan AR, Srinivasan SR, Chen W, Sultana A, Berenson GS: Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study. Metabolism. 2008, 57: 612-616. 10.1016/j.metabol.2007.12.003.
Breimer LH, Wannamethee G, Ebrahim S, Shaper AG: Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995, 41: 1504-1508.
Ekblom K, Marklund SL, Jansson JH, Osterman P, Hallmans G, Weinehall L, Hultdin J: Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting. Circ Cardiovasc Genet. 2010, 3: 340-347. 10.1161/CIRCGENETICS.109.861773.
Vítek L, Novotný L, Sperl M, Holaj R, Spácil J: The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006, 21: 408-414. 10.1159/000091966.
Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vítek L, Bulmer AC, Wagner KH: Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci. 2013, 125: 257-264. 10.1042/CS20120661.
Ranheim T, Halvorsen B: Coffee consumption and human health–beneficial or detrimental?–Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 2005, 49: 274-284. 10.1002/mnfr.200400109.
Higdon JV, Frei B: Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006, 46: 101-123. 10.1080/10408390500400009.
Pham NM, Yoshida D, Morita M, Yin G, Toyomura K, Ohnaka K, Takayanagi R, Kono S: The relation of coffee consumption to serum uric Acid in Japanese men and women aged 49–76 years. J Nutr Metab. 2010, pub ahead of print 27 Jul 2010. doi: 10.1155/2010/930757
Ohnaka K, Kono S, Inoguchi T, Yin G, Morita M, Adachi M, Kawate H, Takayanagi R: Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Pract. 2010, 88: 103-110. 10.1016/j.diabres.2009.12.022.
Tokuda K, Tanimoto K: A new method of measuring bilirubin in serum by vanadic acid (Japanese). Rinsho Kagaku. 1993, 22: 116-122.
Hirata M, Takanashi N, Oka M, Tsukada Y: Application of unsensitixed soap-free latex to a new assay principle for HbA1c and its evaluation (Japanese). Igaku-to-Yakugaku. 1995, 34: 125-136.
Barrett PV: Hyperbilirubinemia of fasting. JAMA. 1971, 217: 1349-1353. 10.1001/jama.1971.03190100033006.
Fevery J: Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology. 1997, 113: 1798-1800.
Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM: Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol. 1989, 42: 172-179. 10.1136/jcp.42.2.172.
Broughton PM, Holder R, Ashby D: Long-term trends in biochemical data obtained from two population surveys. Ann Clin Biochem. 1986, 23: 474-486.
Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2003, 55: 65-85.
Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohota T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N: Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. Journal Atheroscler Thromb. 2008, 15: 116-121. 10.5551/jat.E560.
Kannel WB, Ellison RC: Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta. 1996, 15: 59-76.
Fukushima Y, Ohie T, Yonekawa Y, Yonemoto K, Aizawa H, Mori Y, Watanabe M, Takeuchi M, Hasegawa M, Taguchi C, Kondo K: Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J Agric Food Chem. 2009, 57: 1253-1259. 10.1021/jf802418j.
Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB: Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993, 9: 293-297. 10.1007/BF00146266.
Cadden IS, Partovi N, Yoshida EM: Possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther. 2007, 26: 1-8.
Ikeda M, Maki T, Yin G, Kawate H, Adachi M, Ohnaka K, Takayanagi R, Kono S: Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest. 2010, 70: 171-179. 10.3109/00365511003650165.
Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP: Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology. 2010, 139: 1699-1710. 10.1053/j.gastro.2010.06.048.